As a holiday gift to providers, the U.S. Department of Health and Human Services (HHS) General Counsel recently issued a strongly worded Advisory Opinion indicating that federal law requires drug manufacturers to deliver...more
1. 340B ADR Process Established -
At long last, more than ten years after Congress directed it to do so, HHS has finalized an alternative dispute resolution (“ADR”) process for both providers and pharmaceutical...more
12/15/2020
/ American Depository Receipts (ADRs) ,
Department of Health and Human Services (HHS) ,
Dispute Resolution ,
Drug Pricing ,
Health Care Providers ,
Manufacturers ,
Outpatient Prospective Payment System (OPPS) ,
Pharmaceutical Industry ,
Prescription Drugs ,
Relief Measures ,
Section 340B
The U.S. Department of Health and Human Services (“HHS”) recently published a final rule on the 340B Drug Pricing Program (“340B Program”), moving the effective date for changes to the program up to January 1, 2019. Making...more
12/18/2018
/ Civil Monetary Penalty ,
Covered Entities ,
Department of Health and Human Services (HHS) ,
Drug Pricing ,
Final Rules ,
Health Care Providers ,
Health Clinics ,
Hospitals ,
Manufacturers ,
Pharmaceutical Industry ,
Prescription Drugs ,
Section 340B